1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Pires, J.R. Taha-Nejad, F. Toepert, F. Ast, T. Hoffmuller, U. Schneider-Mergener, J. Kuhne, R. Macias, M.J. Oschkinat, H. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C8 H18 114.229 N-OCTANE non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 314 1147 1156 10.1006/jmbi.2000.5199 11743730 Solution structures of the YAP65 WW domain and the variant L30 K in complex with the peptides GTPPPPYTVG, N-(n-octyl)-GPPPY and PLPPY and the application of peptide libraries reveal a minimal binding epitope. 2001 10.2210/pdb1k9q/pdb pdb_00001k9q 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 4682.166 65 kDa Yes-associated protein Wild type WW domain 1 syn polymer 527.593 WW domain binding protein-1 residues 149-153 P3G 1 syn polymer 114.229 N-OCTANE 1 syn non-polymer YAP65 WBP-1 no no FEIPDDVPLPAGWEMAKTSSGQRYFLNHIDQTTTWQDPRK FEIPDDVPLPAGWEMAKTSSGQRYFLNHIDQTTTWQDPRK A polypeptide(L) no yes GPPPY(NH2) GPPPYX B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_conn struct_ref_seq_dif struct_site repository Initial release Version format compliance Version format compliance Other Other Data collection Database references Derived calculations 1 0 2001-12-28 1 1 2008-04-27 1 2 2011-07-13 1 3 2012-12-12 1 4 2013-03-13 1 5 2021-11-10 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_conn.pdbx_leaving_atom_flag _struct_ref_seq_dif.details _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id 1JMQ contains YAP65 (L30K mutant) WW domain in Complexed with GTPPPPYTVG peptide 1E0M contains Prototype Ww Domain 1EG3 contains Dystrophin Ww Domain Fragment 1EG4 contains Dystrophin Ww Domain Fragment In Complexed With beta-Dystroglycan Peptide 1I5H contains Rnedd4 Wwiii Domain-Renac Bp2 Peptide Complex 1K9R contains YAP65 WW domain complexed with Acetyl-PLPPY RCSB Y PDBJ 2001-10-30 REL REL OCT N-OCTANE This sequence was synthetically obtained, by semiautomated spot synthesis in a cellulose support. sample This sequence was synthetically obtained by spot synthesis in a cellulose support. 9606 Homo sapiens sample structures with the lowest energy 200 20 2D NOESY 2D NOESY 100mM NaCl 6 1 atm 288 K 100mM NaCl 6 1 atm 288 K 2000K, 200 runs, Force constants for NOE 50kcal mol-1 rad-2, 422 restraints Simulated anneling 1 lowest energy phosphate buffer 10mM, NaCl 100mM, DTT 0.1mM, EDTA 0.1mM, pH 6, WW domain 1.2mM, ligand 2.4mM H2O (10% D2O) phosphate buffer 10mM, NaCl 100mM, DTT 0.1mM, EDTA 0.1mM, pH 6, WW domain 1.2mM, ligand 2.4mM D2O Bruker processing XwinNMR 2.6 Kraulis, P.J. data analysis ANSIG 3.3 Brunger, A.T. refinement X-PLOR 3.1 600 Bruker DRX 750 Bruker DMX OCT 2 3 OCT OCT 2 B PHE 5 n 1 PHE 5 A GLU 6 n 2 GLU 6 A ILE 7 n 3 ILE 7 A PRO 8 n 4 PRO 8 A ASP 9 n 5 ASP 9 A ASP 10 n 6 ASP 10 A VAL 11 n 7 VAL 11 A PRO 12 n 8 PRO 12 A LEU 13 n 9 LEU 13 A PRO 14 n 10 PRO 14 A ALA 15 n 11 ALA 15 A GLY 16 n 12 GLY 16 A TRP 17 n 13 TRP 17 A GLU 18 n 14 GLU 18 A MET 19 n 15 MET 19 A ALA 20 n 16 ALA 20 A LYS 21 n 17 LYS 21 A THR 22 n 18 THR 22 A SER 23 n 19 SER 23 A SER 24 n 20 SER 24 A GLY 25 n 21 GLY 25 A GLN 26 n 22 GLN 26 A ARG 27 n 23 ARG 27 A TYR 28 n 24 TYR 28 A PHE 29 n 25 PHE 29 A LEU 30 n 26 LEU 30 A ASN 31 n 27 ASN 31 A HIS 32 n 28 HIS 32 A ILE 33 n 29 ILE 33 A ASP 34 n 30 ASP 34 A GLN 35 n 31 GLN 35 A THR 36 n 32 THR 36 A THR 37 n 33 THR 37 A THR 38 n 34 THR 38 A TRP 39 n 35 TRP 39 A GLN 40 n 36 GLN 40 A ASP 41 n 37 ASP 41 A PRO 42 n 38 PRO 42 A ARG 43 n 39 ARG 43 A LYS 44 n 40 LYS 44 A GLY 3 n 1 GLY 3 B PRO 4 n 2 PRO 4 B PRO 5 n 3 PRO 5 B PRO 6 n 4 PRO 6 B TYR 7 n 5 TYR 7 B NH2 8 n 6 NH2 8 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N ALA 20 A N ALA 16 A O TYR 28 A O TYR 24 A N PHE 29 A N PHE 25 A O THR 38 A O THR 34 11 A A OG HE21 SER GLN 23 26 1.57 11 A A H O ASN THR 31 36 1.58 12 A A H O ASN THR 31 36 1.59 16 A A O HH11 PRO ARG 42 43 1.58 1 A ILE 7 -167.65 71.34 1 A PRO 12 -71.88 -159.13 1 A ALA 20 -172.73 149.16 1 A SER 23 -176.11 -154.70 1 A SER 24 -66.68 74.58 1 A ARG 27 -63.97 74.27 1 A GLN 35 54.94 72.02 1 A TRP 39 -63.70 -160.83 1 A ASP 41 -177.54 -59.90 2 A GLU 6 54.35 99.21 2 A LEU 13 54.64 176.96 2 A SER 23 178.56 -85.68 2 A SER 24 -128.30 -80.52 2 A ARG 27 -64.93 72.41 2 A GLN 35 53.93 75.30 2 A TRP 39 -109.36 -66.99 3 A GLU 6 -79.19 -72.89 3 A PRO 12 -73.62 -159.59 3 A SER 23 -176.82 59.98 3 A SER 24 48.09 90.01 3 A ARG 27 -65.16 73.57 3 A TRP 39 -63.54 -149.63 3 A ASP 41 -175.99 -60.13 4 A ILE 7 -52.84 108.45 4 A ASP 9 -113.84 77.63 4 A ASP 10 -174.39 -60.99 4 A PRO 12 -71.62 -87.89 4 A ALA 20 -170.21 145.63 4 A SER 23 -176.43 -151.70 4 A SER 24 -66.55 74.77 4 A ARG 27 -63.98 74.10 4 A TRP 39 -100.38 -64.95 4 A ARG 43 -101.52 78.78 5 A ASP 9 -91.06 41.64 5 A ASP 10 -173.40 83.65 5 A LEU 13 53.56 -179.30 5 A ALA 20 -171.19 145.66 5 A SER 23 -178.08 -153.65 5 A ARG 27 -65.67 75.41 5 A GLN 35 54.06 71.07 5 A TRP 39 -106.62 -61.33 6 A GLU 6 -53.67 172.16 6 A ASP 10 -67.39 74.62 6 A VAL 11 54.16 99.06 6 A PRO 12 -71.69 -158.38 6 A LEU 13 -51.44 177.02 6 A SER 23 -177.89 -153.07 6 A SER 24 -53.73 -70.17 6 A ARG 27 -65.72 69.08 6 A GLN 35 51.98 78.66 6 A TRP 39 -102.34 -67.14 6 A GLN 40 -58.07 103.07 6 A ARG 43 -81.73 -74.79 7 A GLU 6 -73.33 -159.73 7 A PRO 8 -72.99 -163.51 7 A VAL 11 -175.06 106.89 7 A PRO 12 -71.10 -159.07 7 A ALA 20 -170.82 142.31 7 A SER 23 -178.58 -155.37 7 A GLN 35 35.75 65.84 7 A ASP 41 -51.87 107.98 7 A ARG 43 -167.94 29.52 8 A GLU 6 -68.24 -161.28 8 A ILE 7 -117.02 68.48 8 A ASP 10 -127.92 -80.49 8 A PRO 12 -72.00 -159.27 8 A SER 23 -179.89 95.69 8 A SER 24 61.37 -78.28 8 A GLN 26 -58.92 89.86 8 A GLN 35 55.36 74.75 8 A GLN 40 50.17 -176.28 8 A ARG 43 -119.15 -78.93 9 A ILE 7 -115.37 72.03 9 A PRO 12 -72.00 -159.46 9 A SER 23 178.71 -152.66 9 A SER 24 -52.59 -80.69 9 A GLN 26 -69.02 71.23 9 A ASP 41 -176.80 -60.03 10 A ASP 9 -103.23 70.47 10 A PRO 12 -72.99 -85.91 10 A ALA 20 -172.11 146.34 10 A SER 23 -175.58 -154.32 10 A SER 24 -66.65 74.37 10 A ARG 27 -63.91 75.92 10 A GLN 35 50.36 77.43 10 A ARG 43 -175.02 33.16 11 A GLU 6 -98.08 -68.13 11 A PRO 8 -75.89 -163.23 11 A ASP 10 -73.52 -80.29 11 A ALA 20 -171.28 148.03 11 A SER 23 -157.87 -154.39 11 A GLN 35 55.49 72.71 11 A TRP 39 -106.84 -64.20 12 A ASP 9 -118.59 52.94 12 A ASP 10 -158.40 -71.73 12 A ALA 20 -171.02 144.82 12 A SER 23 -175.76 58.00 12 A SER 24 50.13 96.24 12 A ARG 27 -63.45 74.46 12 A ASP 41 56.22 94.30 12 A ARG 43 53.24 96.63 13 A PRO 8 -72.46 -166.35 13 A PRO 12 -71.44 -159.48 13 A LEU 13 -51.42 177.51 13 A SER 23 52.15 95.41 13 A SER 24 63.35 -77.28 13 A GLN 26 51.08 74.51 13 A GLN 35 55.30 70.72 13 A GLN 40 52.35 -160.48 14 A GLU 6 -174.88 124.84 14 A PRO 12 -71.23 -159.05 14 A SER 23 -177.12 -152.52 14 A ARG 27 -65.86 70.04 14 A TRP 39 -77.99 -149.05 14 A ASP 41 -176.51 -60.06 14 A ARG 43 -151.57 -78.82 15 A GLU 6 -173.79 -156.01 15 A ASP 10 -175.30 -64.72 15 A PRO 12 -71.37 -87.93 15 A SER 23 -163.56 -147.81 15 A GLN 26 -60.69 89.05 15 A GLN 35 55.11 75.53 15 A ASP 41 62.63 132.63 16 A GLU 6 -87.41 49.62 16 A ASP 10 -151.07 53.17 16 A LEU 13 54.05 -177.08 16 A SER 23 53.82 -139.82 16 A SER 24 -68.29 70.59 16 A GLN 26 -55.92 92.94 16 A ARG 27 -66.72 89.92 16 A GLN 40 -52.35 101.55 16 A ARG 43 -176.87 -75.62 17 A GLU 6 53.89 -159.14 17 A PRO 12 -73.52 -89.94 17 A LEU 13 -171.42 -165.19 17 A ALA 20 -171.30 144.66 17 A SER 23 -176.27 -157.72 17 A SER 24 -66.87 73.92 17 A ARG 27 -67.20 80.54 17 A ASP 34 -141.48 17.65 17 A GLN 35 49.43 81.86 17 A GLN 40 -57.97 -165.65 18 A PRO 8 -72.55 -163.39 18 A ASP 9 -105.97 61.12 18 A ASP 10 -153.11 21.75 18 A PRO 12 -72.19 -159.65 18 A SER 23 55.10 -142.74 18 A SER 24 -50.22 -81.04 18 A GLN 26 -52.68 94.64 18 A GLN 35 57.38 81.14 18 A ASP 41 -179.77 -59.35 18 A ARG 43 -175.26 67.76 19 A ASP 9 -61.95 84.57 19 A ASP 10 -177.09 -34.13 19 A LEU 13 57.28 173.20 19 A SER 23 -178.49 -91.61 19 A GLN 35 54.96 76.68 19 A TRP 39 -103.70 -60.23 19 A ARG 43 -174.83 -56.45 20 A PRO 8 -72.83 -163.14 20 A ASP 9 -156.65 23.38 20 A LEU 13 58.61 -175.32 20 A SER 23 -177.70 103.34 20 A GLN 26 -59.00 90.12 20 A ARG 27 -63.48 85.23 20 A GLN 35 55.01 72.75 20 A GLN 40 -51.24 94.50 20 A ARG 43 -151.49 19.82 YAP65 WW domain complexed to N-(n-octyl)-GPPPY-NH2 1 N N 2 N N 3 N N covale 1.490 one B OCT 2 C C1 OCT 1_555 B GLY 3 B N GLY 1 1_555 covale 1.304 both B TYR 7 B C TYR 5 1_555 B NH2 8 B N NH2 6 1_555 STRUCTURAL PROTEIN WW domain, YAP65, beta-sheet proteins, ligands, proline-rich peptides, STRUCTURAL PROTEIN YAP1_HUMAN UNP 1 165 P46937 FEIPDDVPLPAGWEMAKTSSGQRYFLNHIDQTTTWQDPRK AAD10950 GB 2 149 4205084 PPPPY 165 204 1K9Q 5 44 P46937 A 1 1 40 149 153 1K9Q 3 7 4205084 B 2 1 5 2 PRO engineered mutation GLY 3 1K9Q B 4205084 GB 149 1 2 amidation NH2 8 1K9Q B 4205084 GB 6 3 anti-parallel anti-parallel A TRP 17 A TRP 13 A LYS 21 A LYS 17 A ARG 27 A ARG 23 A ASN 31 A ASN 27 A THR 36 A THR 32 A THR 38 A THR 34 BINDING SITE FOR RESIDUE OCT B 2 B OCT 2 Software 1 B GLY 3 B GLY 1 1 1_555